相关实验视频

Updated: Jan 9, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

辐射疗法在晚期/转移性肝脏内胆固醇癌中不断变化的作用

Deepti Sharma¹, Babu Lal Meena²

¹Department of Radiation Oncology, Institute of Liver and Biliary Sciences, New Delhi 110070, India. drdeeptisharma16@gmail.com.

World journal of gastrointestinal pharmacology and therapeutics

|December 11, 2025

概括

立体性身体辐射疗法 (SBRT) 显著改善了晚期肝内胆管癌 (iCCA) 的存活率和局部控制. 这种非侵入性治疗提高了切除和移植资格,为iCCA患者提供了新的希望.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学

背景情况:

肝脏内胆管癌 (iCCA) 是一种具有挑战性的肝癌.
晚期和转移性阶段往往具有有限的治疗选择.

研究的目的:

审查对先进/转移性iCCA的立体性身体辐射疗法 (SBRT) 的疗效.
探索SBRT在改善生存,局部控制和治疗资格方面的作用.

主要方法:

评估SBRT在不可切除,转移和边界切除iCCA中的研究的综述.
对结果的分析,包括整体存活率,局部控制率和R0切除率.
评估SBRT与全身疗法的整合及其对移植的影响.

主要成果:

高剂量的SBRT (>75 Gy) 改善了不可切割的iCCA中15-24个月的平均整体存活期.
先进的运动管理在一年内实现了>70%的局部控制.
新辅助性SBRT将R0切除率提高到60%-75%,并扩大肝移植资格.

结论:

SBRT是一种iCCA的变革性,非侵入性疗法,可以改善减轻症之外的结果.
它增强了局部控制,生存和治疗治疗的资格,如切除和移植.
需要进一步的研究来优化SBRT协议和对iCCA患者的选择.

关键词:

先进的先进的先进的先进的先进的在肝脏内发生的胆管癌,胆管癌.转移性转移性辐射疗法是一种疗法.刻板印象性的身体辐射疗法

更多相关视频

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...